A phase Ib trial to evaluate the safety, tolerability and pharmacokinetics of multiple ascending oral dose of ALZ-801 in healthy elderly volunteers for the treatment of Alzheimer's Disease.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 02 Nov 2017

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

23 Oct 2017 Results published in the Clinical Pharmacokinetics
17 Jul 2017 According to an Alzheon meddia release, data from this trial will be presented at the Alzheimers Association International Conference 2017.
30 Mar 2017 Results from this and another phase Ib trial (CT profile 700266592) Presented at the 13th International Conference on Alzheimer's and Parkinson's Diseases, according to an Alzheon Inc. media release

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com